xLM - Continuous Validation
IT Services and IT ConsultingFlorida, United States51-200 Employees
Are you looking to reduce GxP validation costs? Would you like to reduce risk, compress timelines while increasing compliance? Are you looking into moving away from CSV into CSA? Are you looking at creating robust digital data integrity program? We provide Continuous Validation managed services and help life science customers with FDA CSA, Data Integrity and GxP Validation services. 😁WHO IS THIS FOR? Our clients range from multi-national pharmaceutical companies to nimble bio-tech and medical device companies. 🤓HOW DO WE HELP? We can help you reduce GxP validation costs by more than 75% and compress timelines by more than 50%. We can help you transition from CSV to CSA. 🛸WHAT DO WE DO? We invented "continuous validation" which increases compliance, reduces risk and helps you get onboarded onto any cloud or on-prem platform. We cover IaaS, PaaS, and SaaS (the entire infrastructure and software stacks). Our managed services exceed the current expectations of the FDA's CSA. 💡 HOW ARE WE DOING THIS? We have built xLM Continuous Validation Platform that helps us automate software validation life-cycle. There is no manual testing. We use our intelligent testing bots to automate validation. 💨WHAT PLATFORMS AND APPS WE HAVE WORKED WITH? Sample Platforms and Apps: ✔Public Cloud (IaaS/PaaS): AWS, Microsoft Azure, GCP ✔Veeva Apps (QualityDocs, QMS, eTMF, CDMS, Safety, CP&C, RIM) ✔Serialization (TraceLink, Axway) ✔QMS (Veeva, AODocs, Intellect, IQVIA) ✔ITSM (ServiceNow, Jira) ✔LIMS (LabVantage, LabWare) ✔ERP (SAP, Oracle) 👏OUTCOMES YOU CAN EXPECT: ✔Your validation workload will be reduced by more than 90%. We do all the heavy lifting on an ongoing basis. ✔100% Regression Testing at a click of a button. ✔Very fast turn around times so that your teams can implement software changes frequently. ✔Your new software releases will be painless. ✔Your test coverage will be more than 10x manual testing. ✔Your validation spend will be reduced by more than 75%.